Page results
-
The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, is the UK's largest dedicated neurological and neurosurgical hospital. It provides comprehensive services for the diagnosis, treatment and care of all conditions that affect the brain, spinal cord, peripheral nervous system and muscles. Services include specialist neurosurgery, a brain tumour unit, the Hyper-acute Stroke Unit (HASU), an acute brain injury unit, the National Prion Clinic, a pioneering neuro-rehabilitation unit, the UK's first interventional MRI scanner, the largest specialised neurosurgical ITU and the only neuromedical ITU in the country. Together with its neighbour, the UCL Queen Square Institute of Neurology, it is a major international centre for research and training.
-
The National Hospital for Neurosurgery at Cleveland Street opened its doors to patients on 4 April 2016. This brand new centre was developed to provide a new home for our Pain Management Centre, a nationally recognized centre of excellence for people with longstanding pain. Set over two floors the centre has group rooms and consulting clinic rooms as well as procedure rooms.Some multiple sclerosis clinics and outpatient appointments for the National Prion Clinic are also held at the centre.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.
-
This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
This service is provided for UCLH patients who are unable to attend hospital appointments by public transport or other means, due to their medical condition.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.